Human immunodeficiency virus (HIV) prevalence is increasing worldwide as people on
antiretroviral therapy are living longer. These patients are often susceptible to debilitating …

People living with HIV (PLWH) are affected by a higher incidence skin disorders, which are
often associated with high morbidity and mortality. In particular, psoriasis affects PLWH …

BACKGROUND: Patients with psoriasis and HIV infection often present with more severe
and treatment-refractory cutaneous disease. In addition, many of these patients have …

Psoriasis is a prevalent systemic immune-mediated disease with cutaneous manifestations.
In HIV-infected patients, psoriasis may have a higher incidence, present atypical and more …

Background: The management of psoriatic disease in HIV-positive patients is challenging.
Psoriasis in HIV-positive patients is often severe, progressive, and resistant to first-and …

Methods To investigate the efficacy and safety of systemic immunosuppressive therapies for
psoriatic disease in HIV-positive individuals, a PubMed search of articles indexed for …

Background: The management of HIV-positive patients with psoriasis is controversial and
limited to individual cases or short series of patients. Objectives: To evaluate the safety and …

Background: Psoriasis is a chronic, inflammatory disease affecting 2-3% of the worldwide
population, and it may worsen with HIV or be detected as HIV cutaneous manifestation. HIV …

Infection with HIV is associated with psoriasis, with an overall prevalence of 5-6%[1].
Because the psoriatic inflammation is mediated by activated T cells and has been reversed …

Psoriasis is a chronic papulosquamous skin disease that is thought to be a T-cell-mediated
autoimmune disorder of keratinocyte proliferation. The association between psoriasis and …